The production of vaccines requires a facility that is able to manufacture. The NRC is, in fact, building such a facility and Mitch Davies can talk to you about how that's progressing.
The relationship you're referring to with Novavax, you're assuming it's a manufacturing relationship but it could have been other things as well. The NRC, of course, is a research organization and does research contracts with its clients.